Health
A target for potential cancer drugs may, in fact, worsen disease – EurekAlert
Researchers reveal a previously unrealized complexity in cancer development, one that raises concerns and caution about targeting…
In recent years, much scientific effort and funding has focused on developing drugs that target an enzyme with the unwieldy name of Src homology 2-containing protein tyrosine phosphatase 2 or more briefly, Shp2.
Shp2 is a phosphotyrosine phosphatase; its…
Continue Reading
-
Noosa News22 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
Noosa News23 hours agoGood character references restricted in rape cases in Queensland
-
General20 hours agoDairy farmers devastated by floods across parts of New South Wales